Elucid
Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk.
$55MSeries D
ParticipantEM
Elevage Medical Technologies
Activity from announced rounds
Activity in this selectionopera-tech-ventures-fb6de763
Elevage Medical Technologies is the investment organization whose official news identifies Nuclera, Imperative Care and Elucid.
Recorded funding activity
Elucid analyzes CT angiography to characterize arterial plaque. Nervonik develops peripheral nerve stimulation, while Imperative Care develops treatments for thromboembolic disease. These company records connect the organization to different diagnostic and treatment technologies.
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $219.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionNervonik
Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions
$52.5MSeries B
Role not disclosedImperative Care
Develops treatments for patients suffering from thromboembolic disease
$100MGrowth
Role not disclosedNuclera
Provides rapid access to functional proteins through benchtop eProtein Discovery System
$12MSeries C+
Role not disclosed